Uncategorized

Trial By Error: So What’s Happening with the MAGENTA Trial?

By David Tuller, DrPH I’ll be in Bristol later this week for the CFS/ME Research Collaborative’s annual conference. I was not welcome last year, since I was at that point engaged in harshly criticizing the organization for its unwillingness to acknowledge that its deputy chair had falsely accused me of libel. This year, things have …

Trial By Error: So What’s Happening with the MAGENTA Trial? Read More »

Trial By Error: The Cochrane Controversy

By David Tuller, DrPH Cochrane–formerly called the Cochrane Collaboration–is respected worldwide for its systematic reviews of medical treatments. These reviews are often cited as the definitive source of information about treatment efficacy and safety. In taking on the thankless task of assessing the data on commonly used interventions, Cochrane performs an invaluable public health service …

Trial By Error: The Cochrane Controversy Read More »

Trial By Error: Professor Edwards’ Letter to MRC’s Fiona Watt

By David Tuller, DrPH Jonathan Edwards, an emeritus professor of medicine at University College London, recently sent a letter to Professor Fiona Watt, executive chairwoman of the UK Medical Research Council. The MRC was the main funder of PACE and has continued to defend the trial and its conduct. In recent years, Professor Edwards has …

Trial By Error: Professor Edwards’ Letter to MRC’s Fiona Watt Read More »

Rhinoviruses have a sweet tooth

Viral infections often lead to alterations in the energy-generating and precursor synthesizing pathways of a cell, to provide the building blocks and energy to produce new virus particles. The latest example is rhinovirus: infected cells mobilize glucose from extra- and intracellular pools, which is essential for viral replication.

Scroll to Top